More research needed on blast induced traumatic brain injury and vestibular pathology

Oct 16, 2009

Physical therapists are calling for definitive vestibular screenings and assessment measures for US military service members with blast-induced traumatic brain injuries (BITBI). According to a Scholarly Opinion Piece in the September issue of Physical Therapy, the scientific journal of the American Physical Therapy Association (APTA), vestibular rehabilitation must be included as part of successful treatment for those who have been injured by blasts and experience vestibular symptoms such as vertigo, gaze instability, and motion intolerance.

"Because vestibular pathology affects the individual's balance and sense of motion, definitive treatment guidelines could have a tremendous impact on the success of for a patient with BITBI," says lead researcher US Army Captain and APTA member Matthew R. Scherer, PT, MPT, NCS.

According to Scherer, although there is limited scientific and medical literature available about the management of orthopedic, integumentary, neurocognitive, and neurobehavioral effects in survivors of blast, there is even less research addressing the vestibular symptoms of these injuries. Scherer emphasizes the need for clinicians and researchers who work with this patient population to develop screening and assessment measures that will enable them to formulate treatment strategies to reduce disability.

"The rehabilitation community has a tremendous opportunity to contribute to the growing body of knowledge by investigating mechanisms of injury and effective recovery strategies," said Scherer. "It's time to gather as much information as possible and create clinical best practices so that we can maximize the recovery of our military service members who have been injured by blasts."

Source: American Association (news : web)

Explore further: 'Beach body' ads investigated after outcry in Britain

Related Stories

Recommended for you

Dutch DSM posts Q1 slump

Apr 29, 2015

Dutch pharmaceutical group DSM posted a 70 million euro first quarter net loss Wednesday despite an 11 percent jump in sales, boosted by higher animal nutrition volumes and favourable exchange rates.

New meds help drugmakers weather strong dollar, other issues

Apr 28, 2015

Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.